Notably, pathways linked to biliary secretion, calcium signaling, and estrogen signaling (hsa04915) were also enriched, aligning with network predictions of estrogen receptor (ESR2) involvement in IBS pathophysiology. Here, ESR1 is linked to irritable bowel syndrome.